- Mylan launches generic version of Prandin
- Mylan launches generic drug for kidney transplant patients
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- Lipitor may be the first statin to switch to OTC
- New cholesterol, obesity guidelines give greater role to statins, call for more research into weight-loss drugs
PITTSBURGH — Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.
Mylan announced the launch of generic fenofibric acid delayed-release capsules in the 45-mg and 135-mg strengths.
The drug is a generic version of Abbott's Trilipix, designed for use in combination with statin drugs and diet to reduce triglycerides and increase high-density lipoprotein or "good" cholesterol.
Various versions of the drug had sales of about $553.6 million during the 12-month period that ended in March, according to IMS Health.